Procalcitonin to Guide Antibiotic Therapy in Acute Respiratory Infections.

08:00 EDT 1st July 2018 | BioPortfolio

Summary of "Procalcitonin to Guide Antibiotic Therapy in Acute Respiratory Infections."

No Summary Available


Journal Details

This article was published in the following journal.

Name: American family physician
ISSN: 1532-0650
Pages: 20-21


DeepDyve research library

PubMed Articles [21551 Associated PubMed Articles listed on BioPortfolio]

Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.

Introduction Although evidence indicates that use of procalcitonin to guide antibiotic decisions for the treatment of acute respiratory infections (ARI) decreases antibiotic consumption and improves c...

Systemic biomarkers in respiratory tract infections.

Respiratory tract infections represent a major cause of morbidity and mortality despite the progress made in their diagnosis and treatment. Since the clinical presentation of a viral or bacterial infe...

Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis.

Although effective for bacterial lower respiratory tract infections (LRTIs), antibiotic treatment is often incorrectly prescribed for non-bacterial LRTIs. Procalcitonin has emerged as a promising biom...

Variation in Outpatient Antibiotic Dispensing for Respiratory Infections in Children by Clinician Specialty and Treatment Setting.

Antibiotics are commonly prescribed for children with acute respiratory infections (ARIs). This study describes the distribution of ARI diagnoses and specifically quantifies antibiotic dispensing for ...

Procalcitonin as guide to therapy in endovascular infections: caveat emptor!

Clinical Trials [13285 Associated Clinical Trials listed on BioPortfolio]

Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter

Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter. The purpose of this study is to compare the ordina...

Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure

Introduction: Acute Heart Failure is frequently descompensated by pulmonary infeccion, but the diagnosis of pulmonary infection sometimes is difficult in these patients due to similar sign...

Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections

In this study the investigators aim to test if C-reactive protein (CRP)or procalcitonin(PCT) - guided strategy allows to reduce the antibiotic use in patients wiht severe sepsis and septic...

Procalcitonin-guided Antibiotic Therapy During Severe Acute Exacerbation of COPD

This study assess whether a procalcitonin guided antibiotic therapy can reduce significantly unnecessary antibiotic prescription during severe exacerbation of COPD requiring mechanical ven...

Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections (PARTI)-Study

Acute respiratory tract infections (ARTI) are among the most frequent reasons for seeking medical attention in primary care. Although from predominantly viral origin, ARTIs are the most im...

Medical and Biotech [MESH] Definitions

A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.

Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E; VESICULAR EXANTHEMA OF SWINE; acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans.

Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.

Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

Quick Search

DeepDyve research library

Relevant Topic

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Searches Linking to this Article